Introduction
Leading pharmaceutical manufacturer acquired ten approved ANDAs for injectable and ophthalmic products through subsidiaries, with an addressable market of 473.2 million dollars, as disclosed in a January 1 filing release.
Also Read: AJC Jewel Manufacturers climbs 3% after launching new subsidiary in Kerala
Share price movement of Caplin Point Laboratories
On January 1, 2026, Caplin Point Laboratories Limited opened at ₹1,849.90, up 0.47% from its previous close of ₹1,841.20. The stock hit a high of ₹1,870.00 and a low of ₹1,793.00. By 2:41 PM, it traded at ₹1,794.75, down 2.52%, with a market capitalisation of ₹13,642.20 crore.
Caplin Point Acquires 10 ANDAs
Caplin Point Laboratories Limited acquired ten approved ANDAs for injectable and ophthalmic products from a multinational generic manufacturer through subsidiaries Caplin Steriles Limited and Caplin One Labs Limited companies today.
The acquired injectable and ophthalmic ANDAs have an addressable market of $473.2 million for the twelve months ended August 2025, according to the company’s January 1, 2026 filing press release.
Stock performance of Caplin Point Laboratories for Period of 1 week, 6 months, and 1 year
Caplin Point Laboratories Ltd declined 6.70% over the past week, fell 8.91% over the past six months, and dropped 26.8% over the past one year.
Also Read: Waaree Energies shares jump after bagging order for supply of 1500 MW solar modules
Shareholding pattern of Caplin Point Laboratories
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
| Promoter | 70.60% | 70.60% | 70.60% |
| FII | 6.50% | 6.20% | 5.70% |
| DII | 2.10% | 2.20% | 2.00% |
| Public | 20.80% | 21.10% | 21.70% |
About Caplin Point Laboratories
Caplin Point Laboratories Limited (NSE: CAPLIPOINT) is a pharmaceutical company focused on Latin America and Africa, with integrated manufacturing facilities, consistent cash flow growth, profitability, revenue performance, and multiple Forbes Asia and Economic Times recognitions.
Stay Ahead with the Latest Stock Market Updates – Click Here
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.
FAQs
Q: Why is Caplin Point Laboratories share price going up today?
A: Caplin Point Laboratories share price is rising after acquiring 10 approved ANDAs with a $473.2 million addressable market.
Q: What does Caplin Point Laboratories Ltd specialize in?
A: Caplin Point Laboratories Ltd specializes in pharmaceutical manufacturing, focusing on injectable, ophthalmic, and finished dosage products for emerging markets.
Q: What is the 52-week high and low of Caplin Point Laboratories stock?
A: Caplin Point Laboratories stock has a 52-week high of ₹2,625.00 and a 52-week low of ₹1,551.05.
